Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1325 of 1863 entries
View as:

Evaluate Mesothelin as a Biomarker for the Clinical Management of Esophageal Adenocarcinoma (EAC)

Phase: N/A Priority: Normal
NCT ID: NCT01393483 Org: User:
Start: 03/31/11 End: 10/22/24 Due: 10/22/25

Intraoperative Radiation Therapy for Locally Advanced or Recurrent Abdomino-pelvic Solid Tumors With the CivaSheet

Phase: N/A Priority: Normal
NCT ID: NCT02902107 Org: User:
Start: 09/09/16 End: 10/17/24 Due: 10/17/25

Proton Re-Irradiation for Recurrent Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03217188 Org: User:
Start: 07/10/17 End: 07/31/25 Due: 07/31/26

Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00200200 Org: User:
Start: 11/19/04 End: 03/13/25 Due: 03/13/26

Lenvatinib and Pembrolizumab in People With Advanced Soft Tissue Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT04784247 Org: User:
Start: 03/18/21 End: 03/31/26 Due: 03/31/27

Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00006380 Org: User:
Start: 09/30/00 End: 03/31/02 Due: 03/31/03

A Study of the Use of Acellular Dermal Matrix for Breast Reconstruction

Phase: N/A Priority: Normal
NCT ID: NCT05316324 Org: User:
Start: 03/23/22 End: 03/31/26 Due: 03/31/27

Temozolomide and Interferon Alfa in Treating Patients With Stage III or Stage IV Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00027742 Org: User:
Start: 05/31/01 End: 06/30/05 Due: 06/30/06

Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin

Phase: N/A Priority: Normal
NCT ID: NCT00397904 Org: User:
Start: 10/31/06 End: 09/30/10 Due: 09/30/11

Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: Feasibility

Phase: N/A Priority: Normal
NCT ID: NCT00617370 Org: User:
Start: 11/30/04 End: 06/30/08 Due: 06/30/09

A Study of Language Interpretation Solutions for People With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06721065 Org: User:
Start: 12/02/24 End: 12/02/29 Due: 12/02/30

A Custom-Designed MR Coil for Spine Radiotherapy Treatment Planning

Phase: N/A Priority: Normal
NCT ID: NCT03170531 Org: User:
Start: 05/23/17 End: 04/26/21 Due: 04/26/22

Yoga for Symptoms of Nerve Damage Caused by Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT03292328 Org: User:
Start: 09/18/17 End: 09/15/20 Due: 09/15/21

TCR Alpha Beta T-cell and CD19 B-cell Depleted Peripheral Blood Stem Cell Transplantation Using the CliniMACS System for Patients With Non-Malignant Hematologic Disorders From Matched or Mismatched, Related or Unrelated Donors

Phase: N/A Priority: Normal
NCT ID: NCT03615144 Org: User:
Start: 07/23/18 End: 11/13/20 Due: 11/13/21

A Study of Botensilimab and Balstilimab for Rectal Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06843434 Org: User:
Start: 02/20/25 End: 02/20/28 Due: 02/20/29

Using a Targeted Cancer Vaccine (Galinpepimut-S) With Immunotherapy (Nivolumab) in Mesothelioma

Phase: N/A Priority: Normal
NCT ID: NCT04040231 Org: User:
Start: 07/24/19 End: 11/14/24 Due: 11/14/25

Combined Estrogen Blockade of the Breast With Exemestane and Raloxifene in Postmenopausal Women With a History of Breast Cancer Who Have No Clinical Evidence of Disease

Phase: N/A Priority: Normal
NCT ID: NCT00200174 Org: User:
Start: 07/31/99 End: 08/31/08 Due: 08/31/09

Anal Sphincter Prosthesis in Treating Patients Who Are Undergoing Surgery for Anal or Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00059891 Org: User:
Start: 01/31/03 End: 10/31/09 Due: 10/31/10

Predicting Effective Therapy in Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03033927 Org: User:
Start: 01/24/17 End: 01/24/26 Due: 01/24/27

Radiotherapy to the Prostate and Dominant Intra-Prostatic Lesion (DIL)

Phase: N/A Priority: Normal
NCT ID: NCT03269422 Org: User:
Start: 08/28/17 End: 08/28/25 Due: 08/28/26

GDC-0084 With Radiation Therapy for People With PIK3CA-Mutated Solid Tumor Brain Metastases or Leptomeningeal Metastases

Phase: N/A Priority: Normal
NCT ID: NCT04192981 Org: User:
Start: 12/06/19 End: 12/31/26 Due: 12/31/27

Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation

Phase: N/A Priority: Normal
NCT ID: NCT02477202 Org: User:
Start: 06/30/15 End: 12/29/22 Due: 12/29/23

Inhaled Doxorubicin in Treating Patients With Primary Lung Cancer or Lung Metastases

Phase: N/A Priority: Normal
NCT ID: NCT00004930 Org: User:
Start: 07/31/99 End: 02/29/04 Due: 02/28/05

Paclitaxel With Trastuzumab and Lapatinib in HER2-Positive Early Stage Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01827163 Org: User:
Start: 04/30/13 End: 01/31/19 Due: 01/31/20

Acupuncture for Symptoms of Nerve Damage

Phase: N/A Priority: Normal
NCT ID: NCT03183037 Org: User:
Start: 06/07/17 End: 05/02/24 Due: 05/02/25